Globus Medical GMED
NYSE GMED
$74.18 -0.34 (-0.46%)
As of: Sep 10, 2026 · 1:35 PM EDT

Globus Medical (GMED) Free Cash Flow Growth (3y) (2014 - 2026)

Analysis

Globus Medical (GMED) Free Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 180.74 Bn 175.14 Bn 7.27 Bn 41.96%
2 Intuitive Surgical 127.56 Bn 122.34 Bn 1.96 Bn 24.84%
3 Medtronic 116.90 Bn 108.08 Bn 6.34 Bn 35.29%
4 Stryker 103.85 Bn 100.37 Bn 4.50 Bn 25.48%
5 Boston Scientific 63.70 Bn 63.16 Bn 3.85 Bn 35.42%
6 Edwards Lifesciences 49.88 Bn 45.63 Bn 1.35 Bn 250.09%
7 Alcon 33.04 Bn 31.59 Bn 1.68 Bn 11.09%
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn 12.01%
9 Steris 20.65 Bn 20.17 Bn 684.20 Mn 9.23%
10 Globus Medical 10.01 Bn 9.42 Bn 548.17 Mn 117.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.50%
Mar 31, 2026 63.37%
Dec 31, 2025 64.30%
Sep 30, 2025 116.98%
Jun 30, 2025 33.59%
Mar 31, 2025 78.76%
Dec 31, 2024 48.33%
Sep 30, 2024 39.58%
Jun 30, 2024 -19.54%
Mar 31, 2024 -21.85%
Dec 31, 2023 7.35%
Sep 30, 2023 -6.94%
Jun 30, 2023 9.38%
Mar 31, 2023 23.16%
Dec 31, 2022 5.82%
Sep 30, 2022 -21.81%
Jun 30, 2022 18.67%
Mar 31, 2022 30.79%
Sep 30, 2021 -2.19%
Jun 30, 2021 40.10%